Basic amounts of the fines should therefore be set as follows:
–
Merck KgaA: EUR 9,5 million
–
Rhône-Poulenc Biochimie SA/Aventis Pharma SA: EUR 4,75 million.
3.3.5. Aggravating circumstances
3.3.5.1. Role of leader in the infringement
Basic amounts of the fines should therefore be set as follows:
Merck KgaA: EUR 9,5 million
Rhône-Poulenc Biochimie SA/Aventis Pharma SA: EUR 4,75 million.
3.3.5. Aggravating circumstances
3.3.5.1. Role of leader in the infringement